Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00393
|
|||||
Drug Name |
Atomoxetine
|
|||||
Synonyms |
(-)-Tomoxetine; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine; Atomoxetine (INN); Attentin (TN); Strattera (TN); Tomoxetin (TN); Tomoxetina; Tomoxetina [Spanish]; Tomoxetine; Tomoxetine [INN]; Tomoxetinum; Tomoxetinum [Latin]
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Attention deficit hyperactivity disorder [ICD11: 6A05] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C17H21NO
|
|||||
Canonical SMILES |
CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
|
|||||
InChI |
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1
|
|||||
InChIKey |
VHGCDTVCOLNTBX-QGZVFWFLSA-N
|
|||||
CAS Number |
CAS 82248-59-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 255.35 | Topological Polar Surface Area | 21.3 | ||
Heavy Atom Count | 19 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
3.7
|
|||||
PubChem CID | ||||||
PubChem SID |
103189006
, 104024503
, 104305955
, 11114266
, 117535667
, 126582523
, 126629698
, 126655720
, 126684045
, 126723363
, 129474852
, 134338009
, 134358577
, 135030248
, 137171620
, 140098827
, 143495940
, 14749997
, 15196878
, 152101253
, 152234173
, 160845669
, 160963637
, 163773677
, 175265837
, 178103695
, 179151249
, 196105295
, 223540968
, 223682620
, 223992935
, 225207579
, 226420765
, 3249493
, 34718779
, 46506160
, 47510014
, 48179683
, 50070867
, 51091800
, 57313676
, 74924255
, 8183809
, 85731218
, 85788174
, 92714045
|
|||||
ChEBI ID |
CHEBI:127342
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Atomoxetine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.